Orbimed Advisors - I MAB ownership

I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of I MAB
ValueSharesWeighting
Q1 2022$1,805,000
-65.7%
111,1200.0%0.03%
-57.4%
Q4 2021$5,266,000
-34.6%
111,1200.0%0.07%
-23.6%
Q3 2021$8,055,000
-13.7%
111,1200.0%0.09%
-5.3%
Q2 2021$9,329,000
+936.6%
111,120
+498.5%
0.09%
+1075.0%
Q1 2021$900,000
-96.9%
18,565
-96.9%
0.01%
-96.8%
Q4 2020$28,576,000
+0.3%
606,0700.0%0.25%
-30.2%
Q3 2020$28,503,000606,0700.36%
Other shareholders
I MAB shareholders Q3 2023
NameSharesValueWeighting ↓
EDBI Pte Ltd 222,136$768,5910.86%
HHLR ADVISORS, LTD. 6,954,442$24,062,3690.43%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 310,499$1,074,3270.30%
Maso Capital Partners Ltd 100,000$3460.23%
Artal Group S.A. 850,000$2,9410.18%
Virtus ETF Advisers LLC 26,347$91,1610.05%
GSA CAPITAL PARTNERS LLP 96,555$3340.03%
CAXTON ASSOCIATES LP 53,793$186,1240.03%
Diametric Capital, LP 13,924$48,1770.02%
Tekla Capital Management LLC 162,580$562,5270.02%
View complete list of I MAB shareholders